Precision Biosciences Inc. Revenue 2018–2025
Precision Biosciences Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Precision Biosciences Inc. revenue for the quarter ending March 31, 2026 was 10.8 M, a 37272.41% increase year-over-year.
- Precision Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 10.9 M, a 86.58% decrease year-over-year.
- Precision Biosciences Inc. annual revenue for 2025 was 34.3 M, a 50.12% decrease from 2024.
- Precision Biosciences Inc. annual revenue for 2024 was 68.7 M, a 40.98% increase from 2023.
- Precision Biosciences Inc. annual revenue for 2023 was 48.7 M, a 94.15% increase from 2022.
- Precision Biosciences Inc. annual revenue for 2022 was 25.1 M.
Precision Biosciences Inc. (DTIL) — Frequently Asked Questions
Precision Biosciences Inc. (DTIL) is a publicly traded US company. It has a market capitalization of $83M. In fiscal 2025 it reported revenue of $34M and net income of -$46M. Explore DTIL's stock price, financial statements, earnings history, margins and key ratios below.
What is Precision Biosciences Inc.'s market cap?
Precision Biosciences Inc. (DTIL) has a market capitalization of $83M.
What is the DTIL stock price?
DTIL trades at $6.45 (-5.98% on the day).
How much revenue does Precision Biosciences Inc. make?
Precision Biosciences Inc. reported revenue of $34M in fiscal 2025.
Is DTIL profitable?
In fiscal 2025, Precision Biosciences Inc. reported net income of -$46M.